drugset / Trial / NCT00485771

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

NCT00485771 ↗

Phase 4 Completed 403 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess olanzapine/fluoxetine combination and lamotrigine comparative efficacy, safety and tolerability in acute and longer term treatment of bipolar depression.

Timeline

Start
2003-11
Primary completion
—
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule — —
Subject Lamotrigine Small molecule — —
Subject Olanzapine Small molecule — —

Indications